Investment Banking
Private Placement, Merger, Acquisition and Reorganization
Investment Management
Haoyue China Healthcare Fund
Capital empowers the success of healthcare companies
Sectors
  • Biopharma
  • Medical Devices
  • Healthcare Services & Digital Health
  • IVD & Life Science
Round
  • Series A funding
  • Series B funding
  • Series C funding
  • Series D funding
  • Series E funding
  • Series F funding
  • Pre-IPO
  • Strategic Financing
  • Crossover
  • Others
Year
  • 2025
  • 2024
  • 2023
{{dealInfo.EXT2}} · {{dealInfo.EXT3}}
{{dealInfo.DESCRIPTION}}
Detail
Our breadth and depth of industry reseach capabilities enable us to produce differentiated insights with a 360-degree view of China’s healthcare industry.
隐于微,显于势:中国器械耗材CDMO的迁跃与价值|HaoYue.Insight
【浩悦资本 × 金投盛源联合发布】自免行业深度研究报告:国产创新药迎来新篇章|HaoYue.Insight
注射笔:GLP-1 爆发驱动下的自我给药装置革命与国产替代浪潮|HaoYue.Insight